is the following...
A recent trial performed in China comparing TruScreen ® with Liquid Based Cytology
and primary HPV testing demonstrated TruSreen® to have higher sensitivity than Liquid
Based Cytology for the detection of high-grade cervical precancer and cancer, and
confirmed the value of TruScreen® for population screening in China.
The test results themselves are great but I think the phrase "population screening" refers to a possible state sponsored national screening program. Which is quite outside the current distribution arrangements. I am reading between the lines but I know this has been a possibility for quite some time.
If it comes off we are all on easy street.
Cheers
from a happy holder.
the bit i like
Add PLT (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
65.0¢ |
Change
-0.045(6.47%) |
Mkt cap ! $113.9M | |||
| Open | High | Low | Value | Volume |
| 69.0¢ | 69.0¢ | 65.0¢ | $9.448K | 13.91K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 2 | 10686 | 65.5¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 69.5¢ | 90 | 1 |
View Market Depth
| Last trade - 13.40pm 10/09/2024 (20 minute delay) ? |
| PLT (ASX) Chart |